Salt Lake City, UT5 Active Studies

Brain Cancer Clinical Trials in Salt Lake City, UT

Find 5 actively recruiting brain cancer clinical trials in Salt Lake City, UT. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
474
Enrolling

Recruiting Brain Cancer Studies in Salt Lake City

RecruitingSalt Lake City, UTNCT05303519

Safusidenib Phase 2 Study in IDH1 Mutant Glioma

This is a 2-part study. The purpose of Part 1 of the study is to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of safusidenib in participants with recurrent/progressive IDH1-...

125 participants
Nuvation Bio Inc.
View Study Details
RecruitingSalt Lake City, UTNCT05535166

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

This is a multi-center, multinational phase 2 trial that aims to explore the use of molecular and clinical risk-directed therapy in treatment of children 0-4.99 years of age with newly diagnosed medul...

120 participants
St. Jude Children's Research Hospital
View Study Details
RecruitingSalt Lake City, UTNCT05765812

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

The primary purpose of the Phase 1 (Dose Escalation) of this study is to identify the dose-limiting toxicities (DLTs) of Debio 0123 combined with temozolomide (TMZ) (Arm A) and with TMZ and radiothera...

116 participants
Debiopharm International SA
View Study Details
RecruitingSalt Lake City, UTNCT06069726

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

This is to study if neoadjuvant atezolizumab therapy is beneficial for patients with recurrent glioblastoma and a low mutational burden....

80 participants
Duke University
View Study Details
RecruitingSalt Lake City, UTNCT06194929

Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

The goal of this interventional clinical trial is to provide proof-of-principle data for the biologic activity of defactinib in combination with avutometinib in brain metastases from melanoma, and to ...

33 participants
University of Utah
View Study Details

About Brain Cancer Clinical Trials in Salt Lake City

Brain cancer includes tumors that originate in the brain (primary) or spread from other areas (metastatic). Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Treatment typically combines surgery, radiation, and chemotherapy, with immunotherapy trials underway.

There are currently 5 brain cancer clinical trials recruiting participants in Salt Lake City, UT. These studies are seeking a combined 474 participants. Research is being sponsored by Nuvation Bio Inc., St. Jude Children's Research Hospital, Debiopharm International SA and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Brain Cancer Clinical Trials in Salt Lake City — FAQ

Are there brain cancer clinical trials in Salt Lake City?

Yes, there are 5 brain cancer clinical trials currently recruiting in Salt Lake City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Salt Lake City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you about next steps.

Are clinical trials in Salt Lake City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salt Lake City studies also compensate for your time and travel.

What brain cancer treatments are being tested?

The 5 active trials in Salt Lake City are testing new therapies including novel drugs, biologics, and treatment approaches for brain cancer.

Data updated March 2, 2026 from ClinicalTrials.gov